Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2017
Transcriptional Mechanisms of Resistance to Anti-PD-1 Therapy
Maria L Ascierto, Alvin Makohon-Moore, Evan J Lipson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 26, 2024
Concordance of Whole-Slide Imaging and Conventional Light Microscopy for Assessment of Pathologic Response Following Neoadjuvant Therapy for Lung Cancer
Julie S Deutsch, Daphne Wang, Krista Y Chen, et al.
Nature Medicine
|
October 30, 2023
Association between pathologic response and survival after neoadjuvant therapy in lung cancer
Julie Stein Deutsch, Ashley Cimino-Mathews, Elizabeth Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 15, 2024
Divergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS-Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade
Samuel Rosner, Sydney Connor, Khaled Sanber, et al.
Journal for Immunotherapy of Cancer
|
October 5, 2018
Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab
Nicolas A Giraldo, Peter Nguyen, Elizabeth L Engle, et al.
Journal for Immunotherapy of Cancer
|
September 15, 2020
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
Joshua E Reuss, Valsamo Anagnostou, Tricia R Cottrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 23, 2019
Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non-Small Cell Lung Cancer
Jiajia Zhang, Zhicheng Ji, Justina X Caushi, et al.
The New England Journal of Medicine
|
April 17, 2018
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
Patrick M Forde, Jamie E Chaft, Kellie N Smith, et al.
Cancer Research
|
December 14, 2018
Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
Valsamo Anagnostou, Patrick M Forde, James R White, et al.
Science (New York, N.Y.)
|
June 11, 2021
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade
Sneha Berry, Nicolas A Giraldo, Benjamin F Green, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 15, 2017
Transcriptional Mechanisms of Resistance to Anti-PD-1 Therapy
Maria L Ascierto, Alvin Makohon-Moore, Evan J Lipson, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
October 26, 2024
Concordance of Whole-Slide Imaging and Conventional Light Microscopy for Assessment of Pathologic Response Following Neoadjuvant Therapy for Lung Cancer
Julie S Deutsch, Daphne Wang, Krista Y Chen, et al.
Nature Medicine
|
October 30, 2023
Association between pathologic response and survival after neoadjuvant therapy in lung cancer
Julie Stein Deutsch, Ashley Cimino-Mathews, Elizabeth Thompson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 15, 2024
Divergent Clinical and Immunologic Outcomes Based on STK11 Co-mutation Status in Resectable KRAS-Mutant Lung Cancers Following Neoadjuvant Immune Checkpoint Blockade
Samuel Rosner, Sydney Connor, Khaled Sanber, et al.
Journal for Immunotherapy of Cancer
|
October 5, 2018
Multidimensional, quantitative assessment of PD-1/PD-L1 expression in patients with Merkel cell carcinoma and association with response to pembrolizumab
Nicolas A Giraldo, Peter Nguyen, Elizabeth L Engle, et al.
Journal for Immunotherapy of Cancer
|
September 15, 2020
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
Joshua E Reuss, Valsamo Anagnostou, Tricia R Cottrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 23, 2019
Compartmental Analysis of T-cell Clonal Dynamics as a Function of Pathologic Response to Neoadjuvant PD-1 Blockade in Resectable Non-Small Cell Lung Cancer
Jiajia Zhang, Zhicheng Ji, Justina X Caushi, et al.
The New England Journal of Medicine
|
April 17, 2018
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
Patrick M Forde, Jamie E Chaft, Kellie N Smith, et al.
Cancer Research
|
December 14, 2018
Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
Valsamo Anagnostou, Patrick M Forde, James R White, et al.
Science (New York, N.Y.)
|
June 11, 2021
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockade
Sneha Berry, Nicolas A Giraldo, Benjamin F Green, et al.
Page
of 4